Judith Hurdman

Judith Hurdman

Auto-generated profile, based on publicly available information

Judith Hurdman

Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
JHJ. Hurdman
J. Hurdman
RCR. Condliffe
R. Condliffe
CEC.A. Elliot
C.A. Elliot
CDC. Davies
C. Davies
CHC. Hill
C. Hill
DKD.G. Kiely
D.G. Kiely
Pulmonary hypertension (PH) is a heterogeneous condition. To date, no registry data exists reflecting the spectrum of disease across the five diagnostic groups encountered in a specialist referral centre.Data was retrieved for consecutive, treatment-naïve cases diagnosed between 2001 and 2010 using a catheter-based approach. 1,344 patients were enrolled, with a mean follow-up of 2.9 yrs.The 3-yr survival was 68% for pulmonary arterial hypertension (PAH), 73% for PH associated with left heart disease, 44% for PH associated with lung disease (PH-lung), 71% for chronic thromboembolic PH (CTEPH) and 59% for miscellaneous PH. Compared with PAH, survival was inferior in PH-lung and superior in CTEPH (p<0.05). Multivariate analysis demonstrated that diagnostic group independently predicted survival. Within PAH, Eisenmenger’s survival was superior to idiopathic PAH, which was superior to PAH associated with systemic sclerosis (p<0.005). Within PH-lung, 3-yr survival in sleep disorders/alveolar hypoventilation (90%) was superior to PH-lung with chronic obstructive pulmonary disease (41%) and interstitial lung disease (16%) (p<0.05). In CTEPH, long-term survival was best in patients with surgically accessible disease undergoing pulmonary endarterectomy.In this large registry of consecutive, treatment-naïve patients identified at a specialist PH centre, outcomes and characteristics differed between and within PH groups. The current system of classification of PH has prognostic value even when adjusted for age and disease severity, emphasising the importance of systematic evaluation and precise classification.

27 September 2012 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
JHJudith Hurdman
Judith Hurdman
RCRobin Condliffe
Robin Condliffe
CECharlie A. Elliot
Charlie A. Elliot
ASAndrew Swift
Andrew Swift
SRSmitha Rajaram
Smitha Rajaram
DKDavid G. Kiely
David G. Kiely
The phenotype and outcome of severe pulmonary hypertension in chronic obstructive pulmonary disease (COPD) is described in small numbers, and predictors of survival are unknown. Data was retrieved for 101 consecutive, treatment-naïve cases of pulmonary hypertension in COPD.Mean±sdfollow-up was 2.3±1.9 years. 59 patients with COPD and severe pulmonary hypertension, defined by catheter mean pulmonary artery pressure ≥40 mmHg, had significantly lower carbon monoxide diffusion, less severe airflow obstruction but not significantly different emphysema scores on computed tomography compared to 42 patients with mild–moderate pulmonary hypertension. 1- and 3-year survival for severe pulmonary hypertension, at 70% and 33%, respectively, was inferior to 83% and 55%, respectively, for mild–moderate pulmonary hypertension. Mixed venous oxygen saturation, carbon monoxide diffusion, World Health Organization functional class and age, but not severity of airflow obstruction, were independent predictors of outcome. Compassionate treatment with targeted therapies in 43 patients with severe pulmonary hypertension was not associated with a survival benefit, although improvement in functional class and/or fall in pulmonary vascular resistance >20% following treatment identified patients with improved survival.Standard prognostic markers in COPD have limited value in patients with pulmonary hypertension. This study identifies variables that predict outcome in this phenotype. Despite poor prognosis, our data suggest that further evaluation of targeted therapies is warranted.

1 October 2013 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
ASAndrew Swift
Andrew Swift
SRSmitha Rajaram
Smitha Rajaram
JHJudith Hurdman
Judith Hurdman
CHCatherine Hill
Catherine Hill
CDChristine Davies
Christine Davies
DKDavid G. Kiely
David G. Kiely

24 January 2013 in Thorax
Verified
Journal Article
Open access
PDF file
SRSmitha Rajaram
Smitha Rajaram
ASAndrew J Swift
Andrew J Swift
ATAdam Telfer
Adam Telfer
JHJudith Hurdman
Judith Hurdman
HMHelen Marshall
Helen Marshall
DKDavid G Kiely
David G Kiely
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary embolism potentially curable by surgery. Perfusion scintigraphy is currently advocated as the imaging modality of choice to exclude CTEPH due to its high sensitivity. We have evaluated the diagnostic utility of lung perfusion MRI. Methods Consecutive patients attending a pulmonary hypertension referral centre undergoing lung perfusion MRI, perfusion scintigraphy, CT pulmonary angiography (CTPA) and right heart catheterisation within 14 days were identified. Results Of 132 patients, 78 were diagnosed as having CTEPH. Lung perfusion MRI correctly identified 76 patients as having CTEPH with an overall sensitivity of 97%, specificity 92%, positive predictive value 95% and negative predictive value 96% compared with perfusion scintigraphy (sensitivity 96%, specificity 90%) and CTPA (sensitivity 94%, specificity 98%). No cases of surgically accessible CTEPH were missed with either modality. Conclusions Lung perfusion MRI has high sensitivity equivalent to perfusion scintigraphy in diagnosing CTEPH but does not require ionising radiation, making it an attractive initial imaging modality to assess patients with suspected CTEPH.

1 January 2012 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
ASAndrew Swift
Andrew Swift
SRSmitha Rajaram
Smitha Rajaram
RCRobin Condliffe
Robin Condliffe
DCDave Capener
Dave Capener
JHJudith Hurdman
Judith Hurdman
DKDavid G Kiely
David G Kiely
Cardiovascular Magnetic Resonance (CMR) imaging is accurate and reproducible for the assessment of right ventricular (RV) morphology and function. However, the diagnostic accuracy of CMR derived RV measurements for the detection of pulmonary hypertension (PH) in the assessment of patients with suspected PH in the clinic setting is not well described.

18 December 2014 in Thorax
Verified
Journal Article
Open access
PDF file
SRS. Rajaram
S. Rajaram
ASA. J. Swift
A. J. Swift
RCR. Condliffe
R. Condliffe
CJC. Johns
C. Johns
CEC. A. Elliot
C. A. Elliot
DKD. G. Kiely
D. G. Kiely
We evaluated the prevalence and prognostic value of CT-pulmonary angiographic (CTPA) measures in 292 treatment naive patients with pulmonary arterial hypertension (PAH). Pulmonary artery calcification (13%) and thrombus (10%) were exclusively seen in PAH-congenital heart disease. Oesophageal dilation (46%) was most frequent in PAH-systemic sclerosis. Ground glass opacification (GGO) (41%), pericardial effusion (38%), lymphadenopathy (19%) and pleural effusion (11%) were common. On multivariate analysis, inferior vena caval area, the presence of pleural effusion and septal lines predicted outcome. In PAH, CTPA provides diagnostic and prognostic information. In addition, the presence of GGO on a CT performed for unexplained breathlessness should alert the physician to the possibility of PAH.